Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 176.70
+4.71 (2.74%)
Jul 10, 2026, 3:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 235.12 billion as of July 10, 2026. Its market cap has decreased by -7.89% in one year.
Market Cap
235.12B
Enterprise Value
278.69B
Revenue
88.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
176.70
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 235.12B, an increase of 3.70%. That is a compound annual growth rate of 0.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 235.12B | 2.82% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 449.16B |
| Ajanta Pharma | 413.08B |
| Gland Pharma | 406.87B |
| Emcure Pharmaceuticals | 343.02B |
| Wockhardt | 296.47B |
| Eris Lifesciences | 198.15B |
| NATCO Pharma | 172.23B |
| Cohance Lifesciences | 168.39B |